Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.

Abstract

The role of endothelin B (ET(B)) receptors in inflammation and nociception was examined using ET(B) receptor knockout mice. Genotyping studies were used with tissues from ET(B)((+/+)), ET(B)((+/-)), and ET(B)((-/-)) mice to confirm the loss of ET(B) receptors. Algesia induced by phenylbenzoquinone was evident in the (+/+) mice, reduced by approximately 80% in the (+/-) mice, and absent in the (-/-) mice. Phenylbenzoquinone-induced algesia in (+/+) mice was inhibited 74% by the ET(B) receptor-selective antagonist A192621 (25 mg/kg p.o.), but unaffected by the ET(A) receptor-selective antagonist SB 234551 (25 mg/kg p.o.). Noninflammatory pain, induced by hotplate, was equivalent between (+/+) and (-/-) mice. The cutaneous inflammatory response to topical arachidonic acid (AA) also was evaluated. Whereas (+/+) mice had a marked inflammatory response to AA, the (+/-), and (-/-) mice had significantly reduced fluid phase responses (37 and 65% inhibition, respectively). Neutrophil infiltration also was reduced in the (+/-) and (-/-) mice (51 and 65% reduction, respectively). Topical administration of A192621 (500 microg/ear) in (+/+) mice inhibited AA-induced swelling (39%), whereas SB 234551 (500 microg/ear) was without effect. Collectively, these results implicate the ET(B) receptor in mediation of inflammatory pain and cutaneous inflammatory responses in mice.

7 Figures and Tables

0100200300'02'04'06'08'10'12'14'16
Citations per Year

882 Citations

Semantic Scholar estimates that this publication has 882 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Griswold1999EndothelinBR, title={Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.}, author={Don E. Griswold and Stephen A. Douglas and Lenox D Martin and T. Gregg Davis and Lawrence W. Davis and Zhaohui Ao and Mark A. Luttmann and Mark A. Pullen and P. Azhahia Nambi and Douglas W. P. Hay and Eliot H. Ohlstein}, journal={Molecular pharmacology}, year={1999}, volume={56 4}, pages={807-12} }